methylprednisolone acetate 80 MG/ML Injectable Suspension
- RxCUI
- 1358617
- RxNorm name
- methylprednisolone acetate 80 MG/ML Injectable Suspension
- Display name
- methylPREDNISolone (Injectable)
- Full name
- methylprednisolone acetate 80 MG/ML Injectable Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 80 mg/ml
- Dose form
- Susp
- Route
- Injectable
- Updated
- 2026-10-15 15:43:16
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| methylprednisolone acetate | 80 MG / 1 ML | methylprednisolone | methylprednisolone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Suspension | 316950 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| methylprednisolone | 6902 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | methylPREDNISolone acetate 80 MG/ML Injectable Suspension | 1 | NAMES |
| RxNorm Name | methylprednisolone acetate 80 MG/ML Injectable Suspension | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1358617 | 1 | CODES |
| MMSL_CODE | 2 linked values | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 25021-821-05 | 25021-821 | methylprednisolone acetate methylprednisolone acetate | Sagent Pharmaceuticals | ANDA201835 |
| 55150-314-01 | 55150-314 | Methylprednisolone Acetate Methylprednisolone Acetate | Eugia US LLC | ANDA211930 |
| 55150-314-25 | 55150-314 | Methylprednisolone Acetate Methylprednisolone Acetate | Eugia US LLC | ANDA211930 |
| 70121-1610-1 | 70121-1610 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA216502 |
| 70121-1610-5 | 70121-1610 | Methylprednisolone acetate Methylprednisolone acetate | Amneal Pharmaceuticals LLC | ANDA216502 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA201835 | 25021-821 | methylprednisolone acetate methylprednisolone acetate | ANDA | Sagent Pharmaceuticals |
| ANDA211930 | 55150-314 | Methylprednisolone Acetate Methylprednisolone Acetate | ANDA | Eugia US LLC |
| ANDA216502 | 70121-1610 | Methylprednisolone acetate Methylprednisolone acetate | ANDA | Amneal Pharmaceuticals LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Acetate | METHYLPREDNISOLONE ACETATE | Eugia US LLC | a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | 2026-04-21 | Warnings, Adverse reactions | 55150-314-25 55150-314-01 55150-314 55150031401 55150031425 1358617 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 823b0010-2b57-4e76-b5ac-4a8c2963438f | 2026-01-21 | Warnings, Adverse reactions | 00009030612 00009030602 1358617 |
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Pharmacia & Upjohn Company LLC | 9a7b3837-e038-48bf-97e9-78ad463760dc | 2026-01-21 | Warnings, Adverse reactions | 00009347501 00009347503 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | de12f38c-ffa1-4d62-b9cb-238a263f6fea | 2025-12-31 | Warnings, Adverse reactions | 70121-1610-5 70121-1610-1 70121-1610 70121161001 70121161005 1358617 |
| DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | A-S Medication Solutions | e8209047-c1e6-4081-a6d3-c603d9ee4f14 | 2025-10-27 | Warnings, Adverse reactions | 1358617 |
| methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Sagent Pharmaceuticals | f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | 2025-03-02 | Warnings, Adverse reactions | 25021-821-05 25021-821 25021082105 1358617 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 22 | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | 20260121 |
| 631f7d3e-5620-4be3-b918-2f0d38a97890 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 19 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20250123 |
| e8209047-c1e6-4081-a6d3-c603d9ee4f14 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 14 | DEPO-MEDROL | 20251027 |
| de12f38c-ffa1-4d62-b9cb-238a263f6fea | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 10 | MethylPREDNISolone Acetate Injectable Suspension, USP (40 mg/mL) and (80 mg/mL) Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20251231 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 9 | Methylprednisolone Acetate Injectable Suspension, USP | 20220131 |
| a363f0cd-9c8e-4622-9271-171706846b96 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 7 | Methylprednisolone Acetate Injectable Suspension, USP | 20240301 |
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 3 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | 20260421 |
| c5ca262e-5558-4065-8ef5-e2e76f3635e5 | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 1 | DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP | 20120201 |
| faf608f3-a13d-4969-b1a6-bb0bc1de2a8e | methylPREDNISolone acetate 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [SCD] | 2 | 1 | MethylPREDNISolone Acetate Injectable Suspension, USP | 20110117 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20260421 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20260121 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20260121 |
| de12f38c-ffa1-4d62-b9cb-238a263f6fea | MethylPREDNISolone Acetate Injectable Suspension, USP (40 mg/mL) and (80 mg/mL) Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 20251231 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251217 |
| 823b0010-2b57-4e76-b5ac-4a8c2963438f | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20251114 |
| a0cbcdb5-f657-49f7-8f86-cc5959d69db0 | methylPREDNISolone Acetate Injectable Suspension, USP Rx only NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED | 20251031 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A. | 20251006 |
| 9a7b3837-e038-48bf-97e9-78ad463760dc | DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP) | Pharmacia & Upjohn Company LLC | 20250818 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | Methylprednisolone Acetate Injectable Suspension, USP | Sagent Pharmaceuticals | 20250302 |
| 631f7d3e-5620-4be3-b918-2f0d38a97890 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL Not For Intravenous Use | Endo USA, Inc. | 20250123 |
| a8b270fb-43bc-46d9-bfde-5f5655efab17 | Methylprednisolone Acetate Injectable Suspension, USP | REMEDYREPACK INC. | 20240725 |
| a363f0cd-9c8e-4622-9271-171706846b96 | Methylprednisolone Acetate Injectable Suspension, USP | Sandoz Inc. | Lisapharma SPA | 20240722 |
| a363f0cd-9c8e-4622-9271-171706846b96 | Methylprednisolone Acetate Injectable Suspension, USP | Sandoz Inc. | Lisapharma SPA | 20240301 |
| f98314ea-a4e4-4f78-987b-3e9b45a08bb4 | Methylprednisolone Acetate Injectable Suspension, USP | Sagent Pharmaceuticals | 20220131 |
| 524c2134-cd0e-4454-b45e-f2c76bedafc1 | MethylPREDNISolone A cetate Injectable Suspension, USP | REMEDYREPACK INC. | 20210811 |
| 769cc1ae-bdf4-47e4-9a9f-c6327bd7dbf4 | MethylPREDNISolone A cetate Injectable Suspension, USP | Teva Parenteral Medicines, Inc. | 20210630 |
| 978b8416-2e88-4816-8a37-bb20b9af4b1d | MethylPREDNISolone Acetate Injectable Suspension, USP | Teva Parenteral Medicines, Inc. | 20210630 |
| be407d75-c347-4adb-b165-5bd23a0a0fe5 | MethylPREDNISolone Acetate Injectable Suspension, USP | Northstar RxLLC | 20210630 |
| 0dcf3d21-87ec-4c93-8736-19837b54cdf9 | Methylprednisolone Acetate Injectable Suspension, USP 40 mg/mL (1 mL) and 80 mg/mL (1 mL) Rx only Single-Dose Vial Not For Intravenous Use | REMEDYREPACK INC. | 20210416 |
| 22f8b874-912a-4da2-ae8d-9b77df8491b1 | Methylprednisolone Acetate Injectable Suspension USP | A-S Medication Solutions | 20190828 |
| 2823a219-0466-5dda-e054-00144ff88e88 | ReadySharp-P80 | Terrain Pharmaceuticals | 20161213 |
| 43775cf1-4477-449a-e054-00144ff88e88 | ReadySharp Anesthetics + Methylprednisolone 80 | Terrain Pharmaceuticals | 20161209 |
| 752845c8-7823-45ad-9bba-16ac8e726454 | National Council for Prescription Drug Programs | 20130401 | |
| c5471b1d-6144-4774-ac4a-da96ba7e8495 | National Council for Prescription Drug Programs | 20120724 | |
| c5cab2df-bbc5-43e5-93e1-f4611d6eb481 | National Council for Prescription Drug Programs | 20120724 | |
| 11505f08-dcaf-40aa-99cb-2d5714d90aef | National Council for Prescription Drug Programs | 20120724 | |
| b7a2a7a1-acae-4b6f-ae0b-15591fc0fb70 | National Council for Prescription Drug Programs | 20120724 | |
| b0d29b11-5614-4fb2-b45f-d19957d89fd7 | National Council for Prescription Drug Programs | 20120724 | |
| ad0e83e8-b0b7-4f22-8dd0-6987e6a0929e | National Council for Prescription Drug Programs | 20120724 | |
| 95186b1b-cb0f-4091-86fe-c57d1d1e4986 | National Council for Prescription Drug Programs | 20120724 | |
| 81b04b55-0a87-43d1-a646-efbef92ea817 | National Council for Prescription Drug Programs | 20120724 | |
| 7d447c1d-6583-4fb6-bf81-cb90bc05b6fe | National Council for Prescription Drug Programs | 20120724 | |
| 6d8db3e1-e343-4dc4-91c4-04d66abb6198 | National Council for Prescription Drug Programs | 20120724 | |
| 58660f81-65a6-40f5-86a5-0c59cba9cc27 | National Council for Prescription Drug Programs | 20120724 | |
| 480595b6-0359-41f2-899f-4084cd256b20 | National Council for Prescription Drug Programs | 20120724 | |
| faf608f3-a13d-4969-b1a6-bb0bc1de2a8e | MethylPREDNISolone Acetate Injectable Suspension, USP | Rebel Distributors Corp | 20110117 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D10AA | Corticosteroids, combinations for treatment of acne | ATC1-4 | methylprednisolone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | methylprednisolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | methylprednisolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | methylprednisolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | D008775 | Methylprednisolone | CHEM | has_ingredient | methylprednisolone |
| MEDRT | D000077555 | Methylprednisolone Acetate | CHEM | has_ingredient | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | methylprednisolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001249 | Asthma | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D001932 | Brain Neoplasms | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methylprednisolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006086 | Graft vs Host Disease | DISEASE | may_prevent | methylprednisolone acetate |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006402 | Hematologic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone |
| MEDRT | D007223 | Infant | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone |
| MEDRT | D007938 | Leukemia | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009182 | Mycosis Fungoides | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone |
| MEDRT | D009461 | Neurologic Manifestations | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012128 | Respiratory Distress Syndrome | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012507 | Sarcoidosis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | ci_with | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone acetate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone acetate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | methylprednisolone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 80 MG/ML (expressed as methylprednisolone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA201835 |
| CODES | ANDA | ANDA211930 |
| CODES | ANDA | ANDA216502 |
| CODES | VUID | 4003433 |
| NAMES | Prescribable Synonym | methylPREDNISolone acetate 80 MG/ML Injectable Suspension |
| NAMES | Tallman Synonym | methylPREDNISolone acetate 80 MG/ML Injectable Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |